In this issue
Issue 44 • October 2021
Roughly two decades after researchers first unveiled the draft sequence of the human genome, an international team of scientists claim to have successfully mapped 100% of the human genome – identifying more than 100 new genes and millions of genetic variations between humans, some of which could play a role in disease.
While this discovery may be ground-breaking, switching to a full model of the human genome could prove to be a challenge for many clinical labs, which will have to adjust to this new map of human physiology. To find out more, we speak to genomics experts to find out what clinical labs can do to keep up with this research.
Elsewhere in this issue, we examine the hurdles standing in the way of Africa becoming a clinical trial powerhouse, ask why practitioners still refer to the body mass index despite noted criticism of its reliability, and speak to the Hollywood techies who are adding a touch of movie magic to medical devices.
For all this, plus the latest insight and analysis from GlobalData, read on.
Eloise Mclennan, editor